You can buy or sell PETX and other stocks, options, ETFs, and crypto commission-free!
Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. Read More NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.
52 Week High
52 Week Low
Yahoo FinanceMay 9
PETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
WILMINGTON, Del., May 09, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Aratana Therapeutics, Inc. (NASDAQ GM: PETX ) regarding possible breaches of fiduciary duties and other violations of law related to Aratana’s agreement to be acquired by Elanco Animal Health Incorporated. Shareholders of Aratana will receive for 0.1481 shares of Elanco per share of Aratana. To learn more about this investigation and your rights, visit: https://www.rigrodskylong.com/cases-aratana...
Yahoo FinanceMay 8
Aratana (PETX) Reports Q1 Loss, Tops Revenue Estimates
CCA (CXW) delivered FFO and revenue surprises of 8.47% and 3.71%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Yahoo FinanceMay 2
MERGER ALERT - PETX, BRSS and KEYW: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
NEW YORK, NY / ACCESSWIRE / May 2, 2019 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Aratana Therapeutics, Inc. (PETX) Merger Announcement: April 26, 2019 Transaction Details: Under the terms of the transaction, Aratana shareholders will receive 0.1481 shares of Elanco Animal Health Incorporated (NYSE:ELAN) common stock and a contingent value rig...
Expected Aug 1, After Hours